600479.SH
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 9.80
+0.41%Aug 25, 2026, 09:42 UTC
Qianjin Pharmaceutical announced a cash dividend of 1.8 yuan per 10 shares (tax included).
Source:Aug 17, 2026, 08:26 UTC
Qianjin Pharmaceutical's subsidiaries received drug registration certificates from China's National Medical Products Administration for four drugs, including Minoxidil Tincture, Ezetimibe Tablets, Amlodipine Benazepril Capsules, and Ursodeoxycholic Acid Capsules.
Source:Aug 3, 2026, 09:18 UTC
Qianjin Pharmaceutical and its subsidiary Qianjin Xiangjiang Pharmaceutical participated in the bidding for the 12th national centralized drug procurement on July 31, 2026, with 4 products provisionally selected, with the procurement period lasting until December 31, 2029.
Source:Jul 20, 2026, 09:37 UTC
Qianjin Pharmaceutical's subsidiary Hunan Qianjin Xiangjiang Pharmaceutical received a drug registration certificate for Baclofen Tablets from the National Medical Products Administration.
Source: